Poland· PL-100028455
Hemorol
A medicinal product containing preparat złożony, registered in Poland by Wrocławskie Zakłady Zielarskie "Herbapol" S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- Wrocławskie Zakłady Zielarskie "Herbapol" S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990086610
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/96c79990-3f33-4a9f-964e-c7de88153030 GET /v1/drugs/96c79990-3f33-4a9f-964e-c7de88153030?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Czopki doodbytnicze",
"source": "urpl",
"strength": "-",
"packaging": "05909990086610 ¦ OTC ¦ 4555\n12 szt.\nOTC ¦ Skasowane ¦ 4556\n6 szt.",
"substance": "Belladonnae radicis extractum spissum (4:1); ekstrahent etanol 70% v/v 20 mg + Benzocainum 100 mg + Extractum compositum spissum (4:1) ex: Extractum compositum spissum (4:1) ex: Cytisi scoparii herba, Hippocastani cortice, Tormentillae rhizoma, Millefolii herba - 20 mg + Chamomillae extractum 50 mg",
"common_name": "Preparat złożony",
"pl_product_id": "100028455",
"pozwolenie_nr": "00866",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.